| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.75B | 45.98B | 39.81B | 39.81B | 37.60B | 34.54B |
| Gross Profit | 11.10B | 12.82B | 11.24B | 11.48B | 11.43B | 11.11B |
| EBITDA | 709.00M | 3.33B | 1.32B | 3.10B | 3.83B | 4.19B |
| Net Income | -542.00M | 1.56B | -190.00M | 1.20B | 2.33B | 2.41B |
Balance Sheet | ||||||
| Total Assets | 35.32B | 41.15B | 37.32B | 36.24B | 33.46B | 32.77B |
| Cash, Cash Equivalents and Short-Term Investments | 9.02B | 7.78B | 8.51B | 7.29B | 7.52B | 10.26B |
| Total Debt | 4.34B | 7.18B | 4.78B | 3.34B | 1.33B | 613.00M |
| Total Liabilities | 15.79B | 20.23B | 17.16B | 15.54B | 13.63B | 14.60B |
| Stockholders Equity | 19.49B | 20.86B | 20.10B | 20.63B | 19.74B | 18.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.82B | 589.00M | 613.00M | -1.79B | 3.65B |
| Operating Cash Flow | 0.00 | -1.14B | 983.00M | 1.43B | -1.23B | 3.83B |
| Investing Cash Flow | 0.00 | -635.00M | -816.00M | -2.98B | -941.00M | -1.59B |
| Financing Cash Flow | 0.00 | 1.04B | 845.00M | 1.15B | -767.00M | -403.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥34.11B | 11.34 | ― | 1.90% | 12.47% | 21.98% | |
74 Outperform | ¥27.01B | 9.04 | ― | 3.66% | -18.88% | 42.17% | |
69 Neutral | ¥39.87B | 25.25 | ― | 3.89% | 9.48% | 17.63% | |
69 Neutral | ¥10.42B | 11.17 | ― | 3.90% | 13.59% | 52.99% | |
67 Neutral | ¥14.36B | 9.03 | ― | 3.88% | 15.50% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥14.87B | 22.37 | ― | 1.11% | 21.85% | 13.02% |